%PDF-1.4
%âăĎÓ
124 0 obj
<>
endobj
126 0 obj
<>stream
2016-12-09T17:42:50-05:00
2017-05-11T19:42-07:00
2017-05-11T19:42-07:00
itext-paulo-155 (itextpdf.sf.net-lowagie.com)
application/pdf
Variants in WFS1 and other Mendelian deafness genes are associated with cisplatin-associated ototoxicity
uuid:f0efd99b-1dd1-11b2-0a00-f208276dce00
uuid:f0efd99e-1dd1-11b2-0a00-1e0000000000
endstream
endobj
118 0 obj
<>
endobj
1 0 obj
<>
endobj
127 0 obj
<>
endobj
128 0 obj
<>
endobj
129 0 obj
<>
endobj
12 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
13 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
14 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
15 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
16 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
17 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
18 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
19 0 obj
<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/Thumb 94 0 R/Type/Page>>
endobj
20 0 obj
<>/ProcSet[/PDF/Text/ImageB]/XObject<>>>/Thumb 100 0 R/Type/Page>>
endobj
21 0 obj
<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/Thumb 106 0 R/Type/Page>>
endobj
22 0 obj
<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/Thumb 112 0 R/Type/Page>>
endobj
130 0 obj
<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/Type/Page>>
endobj
161 0 obj
[168 0 R 169 0 R 170 0 R 171 0 R 172 0 R 173 0 R]
endobj
162 0 obj
<>stream
q
539.3594055 0 0 83.3014526 36.3202972 660.6985474 cm
/Im0 Do
Q
BT
/T1_0 1 Tf
10 0 0 10 105.56995 562.99985 Tm
( Published OnlineFirst December 30, 2016.)Tj
/T1_1 1 Tf
-7.55699 0 Td
(Clin Cancer Res\240)Tj
/T1_0 1 Tf
0 1 TD
(\240 )Tj
0 1.00001 TD
(Heather E. Wheeler, Eric R Gamazon, Robert Frisina, et al. )Tj
/T1_2 1 Tf
0 1 TD
(\240 )Tj
/T1_3 1 Tf
18 0 0 18 30 602.99997 Tm
(associated with cisplatin-associated ototoxicity)Tj
8.16899 1 Td
( and other Mendelian deafness genes are)Tj
/T1_4 1 Tf
-2.778 0 Td
(WFS1)Tj
/T1_3 1 Tf
-5.39099 0 Td
(Variants in )Tj
ET
30 442 552 101 re
0 0 m
S
BT
/T1_0 1 Tf
11 0 0 11 120.94202 515.99997 Tm
(\240 )Tj
/T1_3 1 Tf
-7.55696 1 Td
(Updated version)Tj
ET
BT
/T1_2 1 Tf
10 0 0 10 141 507.99994 Tm
(\240 )Tj
/T1_0 1 Tf
16.73097 1 Td
( )Tj
0 0 1 rg
-15.11898 0 Td
(10.1158/1078-0432.CCR-16-2809)Tj
0 g
-1.61199 0 Td
(doi:)Tj
0 1.00001 TD
(Access the most recent version of this article at:)Tj
ET
BT
/T1_0 1 Tf
11 0 0 11 120.94202 474.99994 Tm
(\240 )Tj
/T1_3 1 Tf
-3.50099 1 Td
(Material)Tj
-3.44499 1.00001 Td
(Supplementary)Tj
ET
BT
/T1_2 1 Tf
10 0 0 10 141 477.99994 Tm
(\240 )Tj
/T1_0 1 Tf
41.12992 1 Td
( )Tj
0 0 1 rg
-41.12992 0 Td
(http://clincancerres.aacrjournals.org/content/suppl/2016/12/30/1078-0432\
.CCR-16-2809.DC1)Tj
0 g
T*
(Access the most recent supplemental material at:)Tj
ET
BT
/T1_0 1 Tf
11 0 0 11 120.94202 441.99994 Tm
(\240 )Tj
/T1_3 1 Tf
-5.05597 1 Td
(Manuscript)Tj
2.05699 1.00001 Td
(Author)Tj
ET
BT
/T1_0 1 Tf
10 0 0 10 141 454.99997 Tm
(edited. )Tj
0 1 TD
(Author manuscripts have been peer reviewed and accepted for publication \
but have not yet been)Tj
ET
BT
/T1_2 1 Tf
10 0 0 10 30 421.99997 Tm
(\240 )Tj
T*
(\240 )Tj
ET
BT
/T1_2 1 Tf
10 0 0 10 30 401.99997 Tm
(\240 )Tj
T*
(\240 )Tj
ET
BT
/T1_2 1 Tf
10 0 0 10 30 381.99997 Tm
(\240 )Tj
T*
(\240 )Tj
ET
30 287 552 95 re
0 0 m
S
BT
/T1_0 1 Tf
11 0 0 11 120.94202 349.99997 Tm
(\240 )Tj
/T1_3 1 Tf
-5.66901 1 Td
(E-mail alerts)Tj
ET
BT
/T1_0 1 Tf
10 0 0 10 295.4996 362 Tm
( related to this article or journal.)Tj
0 0 1 rg
-15.44996 0 Td
(Sign up to receive free email-alerts)Tj
ET
BT
0 g
/T1_0 1 Tf
11 0 0 11 120.94202 316.99994 Tm
(\240 )Tj
/T1_3 1 Tf
-6.38997 1 Td
(Subscriptions)Tj
0.556 1.00001 Td
(Reprints and )Tj
ET
BT
/T1_0 1 Tf
10 0 0 10 141 319.99994 Tm
(\240 )Tj
13.46496 1 Td
(.)Tj
0 0 1 rg
-6.85098 0 Td
(pubs@aacr.org)Tj
0 g
-6.61398 0 Td
(Department at)Tj
0 1.00001 TD
(To order reprints of this article or to subscribe to the journal, contac\
t the AACR Publications)Tj
ET
BT
/T1_0 1 Tf
11 0 0 11 120.94202 294.99997 Tm
(\240 )Tj
/T1_3 1 Tf
-5.66901 1 Td
(Permissions)Tj
ET
BT
/T1_0 1 Tf
10 0 0 10 141 286.99994 Tm
(\240 )Tj
16.63094 1 Td
(.)Tj
0 0 1 rg
-10.01696 0 Td
(permissions@aacr.org)Tj
0 g
-6.61398 0 Td
(Department at)Tj
T*
(To request permission to re-use all or part of this article, contact the\
AACR Publications)Tj
ET
BT
/T1_0 1 Tf
9 0 0 9 283.24257 1.99997 Tm
(Research. )Tj
0.24098 1 Td
(on May 11, 2017. \251 2016 American Association for Cancer)Tj
0 0 1 rg
-13.61496 0 Td
(clincancerres.aacrjournals.org )Tj
0 g
-8.11398 0 Td
(Downloaded from )Tj
ET
BT
/T1_0 1 Tf
9 0 0 9 96.63571 769.99997 Tm
(Author manuscripts have been peer reviewed and accepted for publication \
but have not yet been edited. )Tj
-0.13649 1 Td
(Author Manuscript Published OnlineFirst on December 30, 2016; DOI: 10.11\
58/1078-0432.CCR-16-2809 )Tj
ET
endstream
endobj
167 0 obj
<>/Filter/FlateDecode/Height 238/Length 73913/Name/X/Subtype/Image/Type/XObject/Width 1541>>stream
Hě×ĎÇŔńęĂn`'ÁńG6R0˛"#AěKHů"9ü¸\âC|ç Ž\Î?9Ä-ě5ë= w#b"`şŤëĺÍźÝJ13;uKń÷ŁUoOuŐ{Ż^őĽEÄ ŕ+CD. ýĄK @Ddč Đş ôGD. ýĄK @Ddč Đş ôGD. ýĄK @Ddč Đş ôGD. ýĄK @Ddč Đş ôGD. ýĄK @Ddč Đş ôGD. ýĄK @Ddč Đş ôGD. ýĄK @Ddč Đş ôGD. ýĄK @Ddč Đş Ŕ˙§Śi꺊lĘĆ˝÷eYÚ˝=
!äYî2×u]QńEöIĚežóUQŚé:¤Đh\yîĹq§śýŠ]ăć&;ŇqÔjm#óqb^ŐśmUUĎI-Á
źÓVämŞiÝsŁ}
Ő§ĹîşIţiÔŽ{ľš[RČ&íLÚ°XĄŰ;Ř
;A;ôŃüýüîlDŻzog^ ýilŚfŃű ś$ÎLÇÓ2쪎×řÍŘżĐyŚÇ$N&oar@1i|âĎXő$ÝžwNś9ߞ͡1î1öÓ&ÄldćDâňůŚ đŇéÇŠ}ĆVťˇÁoŰvÜTŁ:Únpťě9iĽ_šABM2Î$Ą)4ďÂG˙&˘ÓʲLăË^UMÓÔu˝p×zíą˝XzŻôç~˝kËś
UëĎ\Ąš:×p+aßýw!sç
+sëůřaŞ,ĘýÚvŠmŰŞŞâŁô§MóŢë5fIť¤YôO|IuUl1-ľË&(ľ|í>˝Y&ćJ%n0nÇâ/Ě2łŮ%Çş¤˝élËnďĺag^Ą8ßŔ4ű|sbĚ4őő /Ŕ>]őłTżIÓńôĂÖ~î~´ęçéôkľmŰŞŞláŢŘÇăńh4ÄwYŚ#ŮnI:˘7eY~Á-Ä°VŞ?łß´MŚňéÓÉÚě§L66C-çMćjď\Ú<ŤtÄWméĹóÇšůŇçJ'yIád2U˛I^ď˝ćľÍvâó,Ď\ž8Đ^ëâŽíĆÚhOu¤ŘŰ MśŘO}4sÜÖ%źÖVXoőĐÓ%.y7ty:b)lĐBi#?ˇŰ3ďĄÝěbkßâÎąű<Î×kěÍąÁJbź{ӧŧóÓ\3÷ńMMKűo=IwgýOť ŔË~˝6MS׾ݡăćÖ[:"SUUéŁcÇ}ď˝wí[Ő{ŻšzÓI(˛üKäÝŘŘŘŢŢ>P˘ĐB×uô?úáęꪼÖizľĹ2tyÖśÚÖ¤áćÍëëë[[[÷îÝÓÉ:áĐĄC'N8yňäšsçÎ?ôëŻŘňńx<bäIo7yđçQšBv Zń2.|ÖÝÂůßh_=ňÍWÖŞ#äटňÎŤe%ˇŢŕ\..Ó˙A˙*Wďˇß¸M;/ívOę^í>ś%=_÷ěq/'ÇÎÇ,1¸ĆŃt<_%}:q K¤Wż$¸ĹÔŤ
÷Ô~Zľi^{+ˇňf*\ň&ĚäkÓ°ó;oľMN{Ż źt]×Eáö>Qíú§O˙xáÂqRWľeŠ×Śmôç_?Ű8uęT\ŐśmYUŮČŰúÓ§Oßšs§Žë§ă§Łz$SŢűŤWŻţćĂ]öLyéü,Ëbń6¸{ŻŐp÷îÝëׯ߸qckkŤőmYG=|ř°ŽŇĘÇăńĂ?yŹŤŢ|ăMÝňĹżóÖIýŠečŽ÷ËűČíl<řěřIÓ=-ŞPËŽěBćJY\jwGV_ýöÚ['WŢ~˙÷ß=ökKW8Ż˙ňJKě%¸N|VşŕBĺę
q´ćŞŞŇÚ´;;;kkkÚFŰť5DÇ!Ö@WöSę^Ó8ú4mc׍Ŵź=ÚÜÜ<{öŹŢ[ĚôâŘiZ´}>˛=]rÄą~=ŠjŔÉ7pZIlKL§)ty´bâf6kŰB{¤k-ČĆĆž3ÇFűíkžQzsűöí'O9sFG´ěŘ]hIc]nçF- ŕĺ˛/PűJľŤţâg?˙řwż~üuý\ÇúmŚ_žŰ˙ŘţíG]ž|9.çyöÂYÝď?ůä~đÚˇ^Ó°+ŁĆŃěZĚýű÷żűÎ;ëëëÍë˝×ë~atVhWýŠô:ٸśiŽ\šríÚľĎ~~tíđÚÚk| mă*ŇüűŃĂ<Ëőë.]Ňůą´îď˙úŰ?ýţęĄ_;XW˙Š|!mÖe]X8=ó˝Ô˙ü/űŐUzż3sÎFQ-)*l]]Tâ.^vś*¤Tťj4jSŰТĆtu7đ˛Ľ5ŞŐ¸ĹJMĽk/ČŽhF7EÄQ.Â*0rdfÎĎĚçĚ*Úlť?żçÇÉű˝ßű˝ďó^ÎWééşÍnîgáékŢűäÁSU˘j â!˘ z˝Ę/˘đDxmĺ|ýŇsw8ąąą6íäÉĐŕiŃ(Ý
úzŕ|đwKő´2úUŇj={655őĆÓŚMŁţHďŢúŢžôä%Ë!}úôéřń㡤¤D˙@ţmŇŁ@IÍü-ŠŹ_ůĂŤ4ôÁ`ľZăââŽ]ťöşŚĐçŐŐŐuuuŮŮŮz1Zţ× CćŐ,ü}ž!"Ă˙ şbóĺyţÎ;ś9ďC
6VUUaÖép[G×ÖÖŇwË%Â}ťpyşüôÄńĄ0LĎ?oim9Uö´´4bđşU
7ßŕM$At'řÚddd444XĂĂÍf38âórÖżTŠú ËîŢŢqQÇ5{öë˛Ňjﳧ\j
Q9-Ŕ935HCÚę§
eŢczÖřäĄUľćţhóâď/ɨ'ĎÔ@M6rüĐqQl_
´@iié%Kęë룣Ł_÷ë: q°×_ŃBáFÓů{ŚnńpČ ¸7;;;ŤŞŞCBB^ęFE§G)O]ŚĐRĹ×Đ°oßžÜÜÜŕŕ`ôłGIęŠáëršĐžÓśR´&:ŘŁhzetđx<˘CW%!!J.ă9Üćää÷őőĄś4ţ§ÓiłŮü+/<Ó:}5üß9ô
kl~~ţmŰcbbTčę*IĎó*!öGł˛˛°íŇ++÷-ŢŹ˝1gÎŤŐĘi çđp8655%%'=wN%ßŕ§4tůâĹ)óćŤ;1Ö=8輪Çá'T źŇőxëőŕŁŃÔŇÍĄâĎ~ľrŐqÝDiîlLŤJGťR°6B"nŇĎKĂ´ç
ĎY<Ş˘NS"všî;Wź[đNădŁÁŔ¤j §rÄ0¤
/MÓâăă'OÜĐĐzîŮł)@IŤArťÝ¨gXXŘČ#qĺŁGĚf3¨-\Ąt ßż¸˘ĺĺ| ˇ.Ëd2ĄôJŻ?ĐÝÝÝŐŐĄĄĄč&-ŹÇăéďďYPPFŃĄÄŻ` łöövČţř
hŢ$a3eĘéÓ§×ŐŐeddlŰží#ř
ÇŔŔ@=#LlGGä1cĆŕűb}ĄűúúZ[[Çś4ÎźľľľM8édRć´ŕÔUoo/Ă÷Χ¸iÓŚ˛˛˛ťwďę3IÓĐşććf`řá_o1naEß0˙3čĘIwUPŻ[>đ˘ľnľ0¨ůâóť*Ç)ŞÂC:WFT
Ű.Ö^ŔČĐŹÉÍ-úKŃń<ôŞpÎi3Ün÷K.Í=2¤ô Î,yý|ž˘b~Ęü aâM)ĐÔ\.×ÓŽNČźĄxEQ$YxÁl65JóŇŔ˛v8ż˙dc^^%đ/Që{ż\x>y¸bÔxYyÂ{ťMzlǸxź¤ŹşČĐ(GZĆ+UdĆf÷ES˙ţŞŠ$ÁiôXT<˘,~č|żnnÖŢHLLěěě
Eló!$$Q˛˛˛
PŔŤWŻŽ\šRr{Ńâââ´ôtÂTĎgÎ ÚęééąŮlgNłŇ6ĄţtZ|yzsF
sçÎíďďGăǡ´śŞjđŃý'r>ĘŔŤ¤äěßż?((¨ŤŤ+##Łžž^E˙zđŔűłçŔ3|şk÷Ž]ť ŁĹëׯß%*R Ö˘EĘËËĹ ü#\NNüĺÂEH˙ŕ_UUľzőjg_?~D^éhDŰťwďÚľkcbb`|+** oüxţTöĽŠš)==Ýnˇ#/8óIożMűşjŐŞČČH>ë~ř^â3g^übß)čžV×`u]ąbEtÄ8QEÁŃÝ
ý#dYnoo///˙éüyxH÷Unh÷D{ĺJUŐ'í_ÍJL4LFŁą§§n-dĘŞŠĽ4ö_ř˘¨3"Éuuu3Ţa ´NbQoĺp8ÂÖÔÔÔřřřŘŘXäe[[[MMMuuőCűĐĐ°°0ĐŔÜ>~üxĐ5X°gOnnŽÁ`W<Ďăë%Éiő˝_.<<\á ń§pĘó?LË`C<&`Źš
˙vÝűýěO.M#
pIŇÜ[4Ů~űVöŚÄÍHŔWS%^[Q"IčQů7ż^}áÂťÝţŕÁ¸ˇâ.üóÂh_N'ŇěčęÜącÇ5kśnÝşsçÎqăĆŮlśV=ˇpáÂ
6@oäyź[°`ÁńŇWŽ\IJJú(ëw
EE˛$mٲe÷îÝc#žű´´´ëׯĎ5ëÎ;&MuëÖ>|ľÝż?×ÖÖ"PIIÉŠS§6~źÁl6CYYŮÍ7§ÄżvS§N˝}űvNNÎćÍëëë?řŕĚř[)ęáű˘ÔŞBdĹ~ÎŢťwďÖ[3f̨ŹŹűCŰŘŻś Ś˛,zĚđPA´H "3%:(H)*âŁĹĆçhDąUËbh`ä-X5
h´bĹŁxi2 Ě(śJ ű°¨ąą Ż$7÷ŢŮÉľě*ŰŻżť>NÝěłĎ:{˝óq¸ttt@äTNntttIIIye
BĄ9sć"ËݸqFkĎ=áááqqq@^_ ËJ%9sćjiq`@@KKKCCďÁŐjľJĽzÜ%łçĚs˝ĄÚRQQşžiIJJşŹ¸Üü yQŔbVťcÇF>-k׎ľˇˇ˙bí:ŘŰ×äď~ţŮUâ¸rĺ
°6mQp8ý|hĺŢ˝{SRR|||ŔdîďÉ